[Prognostic factors in light chain amyloidosis]. / Prognosztikai tényezok könnyulánc-amyloidosisban.
Orv Hetil
; 156(39): 1577-84, 2015 Sep 27.
Article
em Hu
| MEDLINE
| ID: mdl-26550915
ABSTRACT
INTRODUCTION:
Light chain amyloidosis is characterized by extracellular deposition of a fibrillar material derived from immunglobulin light chain fragments.AIM:
The aim of the authors was to assess survival depending on cardiac involvement, therapy, and presence of myeloma.METHOD:
The authors studied a retrospective cohort of 29 patients with light chain amyloidosis (13 kappa, 16 lambda) treated in their institution between 2005 and 2014.RESULTS:
Twenty-one patients had primary amyloidosis, while 8 had coexisting multiple myeloma. One, two and three or more organs were involved in 4, 8, and 17 patients, respectively. Cardiac involvement (22 cases) inversely correlated with survival. Fifteen (52%) patients received chemotherapy only, while 14 (48%) underwent autologous stem cell transplantation with a median survival of 87 and 11.4 months, respectively. Two patients had heart transplantation and survived 70 and 30 months. Median overall survival was 75.8 months.CONCLUSIONS:
Cardiac transplantation followed by autologous stem cell transplantation is feasible in selected patients with light chain amyloidosis and heart failure.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transplante de Coração
/
Transplante de Células-Tronco
/
Insuficiência Cardíaca
/
Amiloidose
/
Mieloma Múltiplo
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Hu
Ano de publicação:
2015
Tipo de documento:
Article